Study of the antimalarial activity of 4-aminoquinoline compounds against chloroquine-sensitive and chloroquine-resistant parasite strains

Journal of Molecular Modeling

Volumn 24, Issue 9, 2018, Pages

  Lawrenson, Alexandre S ^a   Cooper, David L ^a   O’Neill, Paul M ^a   Berry, Neil G ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Aminoquinolines; Antimalarials; K1; Malaria; NF54; QSAR

Indexed keywords

4 AMINOQUINOLINE DERIVATIVE; AMODIAQUINE; ANTIMALARIAL AGENT; CHLOROQUINE; DEETHYLAMODIAQUINE; HEMATIN; 4-AMINOQUINOLINE; AMINOQUINOLINE DERIVATIVE;

ANTIMALARIAL ACTIVITY; ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; IC50; MACHINE LEARNING; MOLECULAR MECHANICS; NONHUMAN; PARTIAL LEAST SQUARES REGRESSION; PHARMACOPHORE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; CHEMISTRY; DRUG RESISTANCE; MOLECULAR MODEL;

AMINOQUINOLINES; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; MACHINE LEARNING; MODELS, MOLECULAR; PLASMODIUM FALCIPARUM;

EID: 85051631534     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-018-3755-z     Document Type: Article

References (52)

1. WHO (2017) World malaria report 2017. World Health Organisation, Geneva
2. Malaria. Centers for Disease Control and Prevention. http://www.cdc.gov/malaria/about/biology/. Accessed 18 December 2017
3. Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK (2000) The structure of malaria pigment β-haematin. Nature 404(6775):307–310. 10.1038/35005132
4. Combrinck JM, Mabotha TE, Ncokazi KK, Ambele MA, Taylor D, Smith PJ, Hoppe HC, Egan TJ (2013) Insights into the role of heme in the mechanism of action of antimalarials. ACS Chem Biol 8(1):133–137. 10.1021/cb300454t
5. Schlitzer M (2007) Malaria chemotherapeutics part I: history of antimalarial drug development, currently used therapeutics, and drugs in clinical development. ChemMedChem 2(7):944–986. 10.1002/cmdc.200600240
6. Turschner S, Efferth T (2009) Drug resistance in Plasmodium: natural products in the fight against malaria. Mini-Rev Med Chem 9(2):206–214. 10.2174/138955709787316074
7. Fidock DA, Eastman RT, Ward SA, Meshnick SR (2008) Recent highlights in antimalarial drug resistance and chemotherapy research. Trends Parasitol 24(12):537–544. 10.1016/j.pt.2008.09.005
8. Sanchez CP, McLean JE, Rohrbach P, Fidock DA, Stein WD, Lanzer M (2005) Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry 44(29):9862–9870. 10.1021/bi050061f
9. Sanchez CP, McLean JE, Stein W, Lanzer M (2004) Evidence for a substrate specific and Inhibitable drug efflux system in chloroquine resistant Plasmodium falciparum strains. Biochemistry 43(51):16365–16373. 10.1021/bi048241x
10. Cooper RA, Ferdig MT, Su XZ, Ursos LMB, Mu JB, Nomura T, Fujioka H, Fidock DA, Roepe PD, Wellems TE (2002) Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol Pharmacol 61(1):35–42. 10.1124/mol.61.1.35
11. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LMB, Sidhu ABS, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE (2000) Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6(4):861–871. 10.1016/s1097-2765(05)00077-8
12. Bray PG, Martin RE, Tilley L, Ward SA, Kirk K, Fidock DA (2005) Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance. Mol Microbiol 56(2):323–333. 10.1111/j.1365-2958.2005.04556.x
13. O’Neill PM, Ward SA, Berry NG, Jeyadevan JP, Biagini GA, Asadollaly E, Park BK, Bray PG (2006) A medicinal chemistry perspective on 4-Aminoquinoline antimalarial drugs. Curr Top Med Chem 6(5):479–507. 10.2174/156802606776743147
14. Leach A, Gillet V (2007) An introduction to chemoinformatics. Springer, Dordrecht. 10.1007/978-1-4020-6291-9
15. Maggiora G, Johnson M (1990) Concepts and applications of molecular similarity. Wiley, New York
16. Katritzky AR, Kulshyn OV, Stoyanova-Slavova I, Dobehev DA, Kuanar M, Fara DC, Karelson M (2006) Antimalarial activity: a QSAR modeling using CODESSA PRO software. Bioorg Med Chem 14(7):2333–2357. 10.1016/j.bmc.2005.11.015
17. Hofheinz W, Jaquet C, Jolidon S (1997) Method of treating chloroquine-resistant malaria with aminoquinoline derivatives. United States Patent US5596002A
18. Ding XC, Ubben D, Wells TNC (2012) A framework for assessing the risk of resistance for anti-malarials in development. Malar J 11 : 292. https://doi.org/10.1186/1475-2875-11-292
19. Spartan′08 (2008) Wavefunction, Irvine, CA. https://www.wavefun.com/
20. Halgren TA (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17(5–6):490–519. 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
21. Todeschini R, Consonni V, Pavan M (2003) Dragon. Software version 3.0. Milano Chemometrics and QSAR Research Group, Milan
22. Fujitsu (2006) ADMEWORKS ModelBuilder, http://www.fqs.pl/en/chemistry/products/admeworks-modelbuilder
23. Shen M, LeTiran A, Xiao YD, Golbraikh A, Kohn H, Tropsha A (2002) Quantitative structure−activity relationship analysis of functionalized amino acid anticonvulsant agents using k nearest neighbor and simulated annealing PLS methods. J Med Chem 45(13):2811–2823. 10.1021/jm010488u
24. Golbraikh A, Tropsha A (2000) Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. Mol Divers 5(4):231–243. 10.1023/a:1021372108686
25. Hudson BD, Hyde RM, Rahr E, Wood J (1996) Parameter based methods for compound selection from chemical databases. Quant Struct-Act Relat 15(4):285–289. 10.1002/qsar.19960150402
26. Livingstone DJ, Rahr E (1989) Corchop – an interactive routine for the dimension reduction of large QSAR data sets. Quant Struct-Act Relat 8(2):103–108. 10.1002/qsar.19890080205
27. Kohavi R, John GH (1997) Wrappers for feature subset selection. Artif Intell 97(1):273–324. 10.1016/S0004-3702(97)00043-X
28. Whitley DC, Ford MG, Livingstone DJ (2000) Unsupervised forward selection: a method for eliminating redundant variables. J Chem Inf Comput Sci 40(5):1160–1168. 10.1021/ci000384c
29. Xu L, Zhang W-J (2001) Comparison of different methods for variable selection. Anal Chim Acta 446(1):475–481. 10.1016/S0003-2670(01)01271-5
30. Goldberg DE (1989) Genetic algorithms in search, optimization, and machine learning. Addison-Wesley, Reading, MA
31. Chun Wei Y (2006) PHAKISO - Pharmacokinetics In Silico, http://www.phakiso.com/
32. The NAG Fortran Library (1991) 15 edn. The numerical algorithms group (NAG). UK, Oxford
33. Wold S, Ruhe A, Wold H, Dunn WJ (1984) The collinearity problem in linear regression. The partial least squares (PLS) approach to generalized inverses. SIAM J Sci Stat Comput 5(3):735–743. 10.1137/0905052
34. 2! J Mol Graph Model 20(4):269–276. 10.1016/s1093-3263(01)00123-1
35. OECD (2014) Guidance document on the validation of (quantitative) structure-activity relationship [(Q)SAR] models. OECD Publishing, Paris. 10.1787/9789264085442-en
36. Golbraikh A, Shen M, Xiao ZY, Xiao YD, Lee KH, Tropsha A (2003) Rational selection of training and test sets for the development of validated QSAR models. J Comput Aided Mol Des 17(2):241–253. 10.1023/a:1025386326946
37. Tropsha A (2010) Best practices for QSAR model development, validation, and exploitation. Mol Inf 29(6–7):476–488. 10.1002/minf.201000061
38. Tropsha A, Gramatica P, Gombar VK (2003) The importance of being Earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb Sci 22(1):69–77. 10.1002/qsar.200390007
39. Johnson JW (2000) A heuristic method for estimating the relative weight of predictor variables in multiple regression. Multivar Behav Res 35(1):1–19. 10.1207/s15327906mbr3501_1
40. Wall M (1996) GAlib: A C++ library of genetic algorithm components, http://lancet.mit.edu/ga/. Massachusetts Institute of Technology, Cambridge
41. 1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine as prototype. J Enzyme Inhib Med Chem 24(1):94–104. 10.1080/14756360801915377
42. Todeschini R, Gramatica P (1997) 3D-modelling and prediction by WHIM descriptors. Part 6. Application of WHIM descriptors in QSAR studies. Quant Struct-Act Relat 16(2):120–125. 10.1002/qsar.19970160204
43. Childs GE, Boudreau EF, Milhous WK, Wimonwattratee T, Pooyindee N, Pang L, Davidson DE (1989) A comparison of the in vitro activities of Amodiaquine and Desethylamodiaquine against isolates of Plasmodium falciparum. Am J Trop Med Hyg 40(1):7–11. 10.4269/ajtmh.1989.40.7
44. Warhurst DC, Steele JCP, Adagu IS, Craig JC, Cullander C (2003) Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties. J Antimicrob Chemother 52(2):188–193. 10.1093/jac/dkg319
45. Todeschini R, Consonni V (2009) Molecular descriptors for Chemoinformatics. Wiley-VCH, Weinheim. 10.1002/9783527628766
46. Gálvez J, Garcia R, Salabert MT, Soler R (1994) Charge indexes. New topological descriptors. J Chem Inf Comput Sci 34(3):520–525. 10.1021/ci00019a008
47. Gálvez J, García-Domenech R, de Julián-Ortiz JV, Soler R (1995) Topological approach to drug design. J Chem Inf Comput Sci 35(2):272–284. 10.1021/ci00024a017
48. Soltzberg LJ, Wilkins CL (1977) Molecular transforms: a potential tool for structure-activity studies. J Am Chem Soc 99(2):439–443. 10.1021/ja00444a021
49. Bray PG, Hawley SR, Mungthin M, Ward SA (1996) Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. Mol Pharmacol 50(6):1559–1566
50. Pearson RG (2005) Chemical hardness and density functional theory. J Chem Sci 117(5):369–377. 10.1007/bf02708340
51. Pearson RG (1963) Hard and soft acids and bases. J Am Chem Soc 85(22):3533–3539. 10.1021/ja00905a001
52. Pisciotta JM, Coppens I, Tripathi AK, Scholl PF, Shuman J, Bajad S, Shulaev V, Sullivan DJ (2007) The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization. Biochem J 402:197–204. 10.1042/bj20060986